Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2015 (2015), Article ID 738571, 4 pages
http://dx.doi.org/10.1155/2015/738571
Case Report

Short Stature in Chronic Kidney Disease Treated with Growth Hormone and an Aromatase Inhibitor

1Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
2Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
3Department of Pediatrics, University of Iowa Children’s Hospital, Iowa City, IA 52242, USA
4Department of Pediatrics, Sinai Hospital, Baltimore, MD 21215, USA

Received 2 March 2015; Accepted 14 May 2015

Academic Editor: Ashraf T. Soliman

Copyright © 2015 Susan R. Mendley et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Gerson, A. Wentz, A. G. Abraham et al., “Health-related quality of life of children with mild to moderate chronic kidney disease,” Pediatrics, vol. 125, no. 2, pp. e349–e357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. N. Fine, E. Kohaut, D. Brown, J. Kuntze, and K. M. Attie, “Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone,” Kidney International, vol. 49, no. 3, pp. 781–785, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Numazawa, W. Handa, C. Hasegawa, and M. Takahashi, “Structure-activity relationships of 2α-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,” Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 4, pp. 353–359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Cavalieri, D. Chakravarti, J. Guttenplan et al., “Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1766, no. 1, pp. 63–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Cavalli, A. Bisi, C. Bertucci et al., “Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach,” Journal of Medicinal Chemistry, vol. 48, no. 23, pp. 7282–7289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. P. Smith, J. Boyd, G. R. Frank et al., “Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man,” New England Journal of Medicine, vol. 331, no. 16, pp. 1056–1061, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Morishima, M. M. Grumbach, E. R. Simpson, C. Fisher, and K. Qin, “Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 12, pp. 3689–3698, 1995. View at Google Scholar · View at Scopus
  8. C. Carani, K. Qin, M. Simoni et al., “Effect of testosterone and estradiol in a man with aromatase deficiency,” The New England Journal of Medicine, vol. 337, no. 2, pp. 91–95, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Hero, E. Norjavaara, and L. Dunkel, “Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6396–6402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. D. I. Shulman, G. L. Francis, M. R. Palmert, and E. A. Eugster, “Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development,” Pediatrics, vol. 121, no. 4, pp. e975–e983, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Bayley and S. R. Pinneau, “Tables for predicting adult height from skeletal age: revised for use with the greulich-pyle hand standards,” The Journal of Pediatrics, vol. 40, no. 4, pp. 423–441, 1952. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Kaskel, “Chronic renal disease: a growing problem,” Kidney International, vol. 64, no. 3, pp. 1141–1151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. “Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation,” American Journal of Kidney Diseases, vol. 35, no. 6, supplement 2, pp. S1–S140, 2000.
  14. N. Mauras, A. Rini, S. Welch, B. Sager, and S. P. Murphy, “Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys,” Metabolism: Clinical and Experimental, vol. 52, no. 8, pp. 964–969, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. C. Brown, G. E. Butler, C. J. H. Kelnar, and F. C. W. Wu, “A double blind, placebo controlled study of the effects of low dose testosterone undecanoate on the growth of small for age, prepubertal boys,” Archives of Disease in Childhood, vol. 73, no. 2, pp. 131–135, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Salehpour, P. Alipour, M. Razzaghy-Azar et al., “A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature,” Hormone Research in Paediatrics, vol. 74, no. 6, pp. 428–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Mauras, L. G. De Pijem, H. Y. Hsiang et al., “Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 3, pp. 823–831, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-C. Carel, E. A. Eugster, A. Rogol, L. Ghizzoni, and M. R. Palmert, “Consensus statement on the use of gonadotropin-releasing hormone analogs in children,” Pediatrics, vol. 123, no. 4, pp. e752–e762, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Mauras, “Strategies for maximizing growth in puberty in children with short stature,” Endocrinology and Metabolism Clinics of North America, vol. 38, no. 3, pp. 613–624, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. W. Grimm and M. C. Dyroff, “Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase,” Drug Metabolism and Disposition, vol. 25, no. 5, pp. 598–602, 1997. View at Google Scholar · View at Scopus